At ASCRS 2025, leading surgeons break down why making the switch from drops to a dropless regimen with OMIDRIA® just makes sense—for patients, surgeons, and staff alike. From cost savings to streamlined staff efficiency, Drs.Scott LaBorwit, Jeffrey Martin, Paul Singh, and Brian Shafer show how OMIDRIA is changing post-op care for the better.
Explore more OMIDRIA insights at omidria.com
OMIDRIA videos are for US HCPs only. This is a studied postoperative cataract surgery regimen that may not be for everyone. Rayner does not recommend any specific combination use of products. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
US-OM-2500046 06/25
